Suppr超能文献

咪康唑与粒细胞集落刺激因子联合化疗在血液系统疾病伴发深部真菌病中的疗效

[Efficacy of combination chemotherapy with miconazole and G-CSF in deep mycosis accompanying hematological diseases].

作者信息

Urabe A, Mizoguchi H, Asano S, Tsuruoka N, Kobayashi M, Hirashima K, Yoshida M, Miura Y, Hirai H, Kamakura M

机构信息

Division of Hematology, Kanto Teishin Hospital.

出版信息

Kansenshogaku Zasshi. 1995 Jun;69(6):701-10. doi: 10.11150/kansenshogakuzasshi1970.69.701.

Abstract

In order to examine the efficacy of the combination chemotherapy with miconazole and G-CSF, patients with deep mycosis and suspected deep mycosis were divided into 3 groups. Group I: miconazole and G-CSF were administered simultaneously. Group II: miconazole was administered later during G-CSF administration. Group III: only miconazole was administered. Of a total of 117 cases 105 cases were analyzed including group I 37 cases, group II 39 cases and group III 29 cases, excluding 12 dropout and inadequate cases. Of the 105 cases, deep mycosis were 31 and suspected deep mycosis were 74, and underlying diseases were hematological malignancies such as leukemias. Efficacy judged mainly by the change of fever was 62.2% (23/37) in group I, 43.6% (17/39) in group II, and 41.4% (12/29) in group III, respectively. Efficacy was better in the patients whose neutrophil counts increased from less than 500/microliters to more than 500/microliters (group I 75.0%, group II 72.7%) than in the patients whose neutrophil counts were less than 500/microliters throughout the time of miconazole administration (group I 33.3%, group II 33.3%). Adverse effects were minimal in 3 groups (group I 15.4%, group II 17.4%, group III 15.6%). It is concluded that the combination with miconazole and G-CSF is effective in the treatment of deep fungal infections.

摘要

为了研究咪康唑与粒细胞集落刺激因子(G-CSF)联合化疗的疗效,将深部真菌病患者和疑似深部真菌病患者分为3组。第一组:同时给予咪康唑和G-CSF。第二组:在给予G-CSF期间较晚给予咪康唑。第三组:仅给予咪康唑。总共117例患者中,分析了105例,包括第一组37例、第二组39例和第三组29例,排除12例退出和不充分的病例。在这105例患者中,深部真菌病31例,疑似深部真菌病74例,基础疾病为白血病等血液系统恶性肿瘤。主要根据发热变化判断的疗效,第一组为62.2%(23/37),第二组为43.6%(17/39),第三组为41.4%(12/29)。中性粒细胞计数从低于500/微升增加到高于500/微升的患者(第一组75.0%,第二组72.7%)的疗效优于咪康唑给药期间中性粒细胞计数始终低于500/微升的患者(第一组33.3%,第二组33.3%)。3组的不良反应均最小(第一组15.4%,第二组17.4%,第三组15.6%)。得出结论:咪康唑与G-CSF联合治疗深部真菌感染有效。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验